Capture your results in NAVICA for self‑reporting.
Find a test kit (contains 2 tests) at your local retailer.
Complete your test, or help others administer if they require assistance.
Wait 15 minutes and view the results.
Test twice over three days, at least 24 (and no more than 48) hours apart. For symptomatic use, a single test can be used.
Requires just a shallow nasal swab that you can do yourself; includes easy-to-follow illustrated instructions.
Convenient, fast results anytime, anywhere; no need for a prescription or to send to a lab.
Designed to detect active COVID-19 infection with or without symptoms. Detects multiple strains including DELTA and OMICRON variants.***
BinaxNOW COVID-19 Antigen Self Test uses the same technology used by doctors and is Made in the USA (due to supply chain constraints and high demand, we are temporarily using nasal swabs from Thailand, South Korea, and the USA).
Each kit box contains two test cards to enable you to test yourself twice over 3 days, with at least 24 (and no more than 48) hours apart. For symptomatic use, a single test can be used.
Indicated for children as young as 2 years old when administered by an adult, and for all people 15 and older to self-administer.
If you use NAVICA and submit your results, they will be available in your result history where you can print, share and refer back to as needed.
If you choose to self report your results, you are automatically reporting your test results to public health authorities which meets reporting requirements. If you receive a positive COVID-19 test result, you should consult with your healthcare provider and follow CDC guidelines, in addition to quarantining yourself.
You can self report up to 2 test results a day, per profile in NAVICA.
No, when the foam end of the swab is inserted, the nasal swab is not sharp and it should not hurt. Sometimes the swab can feel slightly uncomfortable or tickly. If you feel pain, please stop the test and seek advice from a healthcare provider.
There are different kinds of tests for COVID-19. Molecular tests (also known as PCR tests) detect genetic material from the virus. Antigen tests detect proteins from the virus. Antigen tests are very specific for the virus, but are not as sensitive as molecular tests. This means that a positive result tends to be accurate, but a negative result does not rule out infection. If your test result is negative, you should discuss with your healthcare provider whether an additional molecular test would help with your care, and when you should discontinue home isolation.
In data submitted to the FDA from a clinical study conducted by Abbott with several leading U.S. research universities, the BinaxNOW COVID-19 Ag Card was compared to an FDA authorized high sensitivity SARS-CoV-2 test and correctly identified 84.6% of positive specimens and 98.5% of negative specimens.
The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country.
Sensitivity refers to a test's ability to designate an individual with disease as positive. Specificity of a test is its ability to designate an individual who does not have a disease as negative.
The test is indicated for all people aged 15 years or older and for children as young as two years old when samples are collected by an adult.
Please reach out to your health insurance provider to determine whether your HSA/FSA account can be used to purchase the test.
Please contact your health insurance provider to determine reimbursement eligibility.
No, this is an antigen test that only detects an active infection. Antibody tests can detect past infections.
No, this is for personal use only and doesn’t provide a documented test result that you can display when traveling. For a documented test result the BinaxNOW COVID-19 Ag Card Home Test may be a better choice. Combined with the NAVICA App and with a negative result, you will have a digital result that may meet travel requirements. This test is offered by eMed.
Each product box has an expiration date and should not be used after that date.
The tests should be stored in a location between 35.6° and 86°F until use. However, if the test is stored outside the temperature range for a short period of time - for a couple of hours up to a day or two, it will still be okay to use. At the time of use, the test and its components should be used at room temperature.
Yes, you will need a timer/watch and it is recommended that gloves are worn during testing.
COVID-19 Serial testing is when one person tests themselves multiple times for COVID-19 on a routine basis, such as every day or every other day. By testing more frequently, you may detect COVID-19 more quickly and reduce spread of infection.
If your first test is negative, you should test again within 3 days, with at least 24 hours (and no more than 48) between tests. If your first or second test is positive, then proteins from the virus that causes COVID-19 have been found in your specimen and you likely have COVID-19.
If you test positive with the BinaxNOW COVID-19 Antigen Self Test, you should self-isolate and seek follow-up care with your healthcare provider to determine the next steps you should take. You may need additional testing, depending on your personal health history and other factors.
Abbott is intently monitoring the mutations of COVID so we can ensure our tests can detect them, as we do with many viruses. Abbott has conducted a computational analysis of the detection of multiple SARS-CoV-2 strains, including the Delta and Omicron variants and predicts no impact to the performance of our BinaxNOW COVID-19 Antigen Self Test.
*See pharmacy for details. Insurance plans may cover up to eight over-the-counter, at-home COVID-19 self tests (four test kits) per covered individual per month.
**The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. For serial testing, the BinaxNOW COVID-19 Antigen Self Test should be performed twice over 3 days, at least 24 hours (and no more than 48 hours) apart. For symptomatic use, a single test can be used.
***Abbott conducted a computational analysis of the detection of multiple SARS-COV-2 Strains, including the DELTA and OMICRON variants, and predicts no impact to the performance of our BinaxNOW™ COVID-19 Antigen Self Test.
Sign up to receive valuable updates from Abbott.
Please click NO to return to the homepage. Alternatively, click YES to acknowledge and proceed.
Based on your current location, the content on this page may not be relevant for your country.